Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

138.15
Delayed Data
As of Apr 09
 -4.35 / -3.06%
Today’s Change
110.74
Today|||52-Week Range
178.41
+6.29%
Year-to-Date
No recent news for Alnylam Pharmaceuticals Inc.

Today’s Trading

Previous close142.50
Today’s open142.76
Day’s range137.26 - 142.76
Volume12,511
Average volume (3 months)628,550
Market cap$16.2B
Data as of 3:59pm ET, 04/09/2021

Growth & Valuation

Earnings growth (last year)+7.96%
Earnings growth (this year)+15.97%
Earnings growth (next 5 years)+55.99%
Revenue growth (last year)+124.28%
P/E ratioNM
Price/Sales30.32
Price/Book15.80

Competitors

 Today’s
change
Today’s
% change
VTRSViatris Inc+0.10+0.75%
INCYIncyte Corp-0.86-1.06%
CTLTCatalent Inc+1.83+1.70%
----
Data as of 4:00pm ET, 04/09/2021

Financials

Next reporting dateMay 6, 2021
EPS forecast (this quarter)-$1.73
Annual revenue (last year)$492.9M
Annual profit (last year)-$858.3M
Net profit margin-174.15%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts